(Reuters) - Pfizer Inc (NYSE:PFE) and its partner BioNTech Se plan to give volunteers who received a placebo in its COVID-19 vaccine trial an option to receive a first dose…
Pfizer and partner BioNTech confirmed they will seek approval from the Food and Drug Administration on Friday for emergency usage of their new COVID-19 vaccine, a major step forward in…
TOKYO -- When Ugur Sahin, co-founder of the German biotech company BioNTech, first picked up an article published in January in the Lancet medical journal about a mysterious virus in…
NEW YORK -- U.S. stocks rallied Monday but closed well below session highs after drugmakers Pfizer and BioNTech announced preliminary "success" in trials of a COVID-19 vaccine candidate.
Exxon Mobil (XOM, -2.9%), Raytheon (RTX, -3.1%) and Pfizer (PFE, -1.6%) are all struggling today as the stocks were shown the door from the Dow Jones Industrial Average.
The path to a COVID-19 vaccine has started to come into view this week, following the stock-moving disclosures of early-stage clinical data for two vaccine candidates and a rigorous new…